This inventor holds 1 USPTO granted patent. Top assignee: Reata Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ingo Janser and His Patent in Pharmaceutical Innovation.
Introduction
Ingo Janser is an inventor associated with Ann Arbor, Michigan, and Reata Pharmaceuticals, Inc. His patent work concerns synthetic triterpenoids and their potential pharmaceutical applications.
Latest Patents
The supplied information identifies one patent associated with Janser: “Synthetic triterpenoids with nitrogen-based substituents at C-17 and methods of use thereof.” The patent describes compounds, including compounds represented by formulas (I) and (II), and pharmaceutical compositions containing them. It also discusses their potential use as antioxidant inflammation modulators and methods for treating diseases and disorders associated with inflammation and cancer. Janser is credited with 1 patent.
Career Highlights
Janser’s listed work connects him with Reata Pharmaceuticals, Inc., a company focused on pharmaceutical research and development. The patent reflects an area of innovation involving compounds intended to address inflammation and cancer-related conditions.
Collaborations
The supplied information lists Christopher F. Bender and Ha Do as Janser’s coworkers. Their names provide context for the professional network associated with his work.
Conclusion
Ingo Janser’s identified patent documents research into synthetic triterpenoids and their potential therapeutic uses, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
